Edwards Lifesciences Corporation (BVMF:E1WL34)
113.40
+0.87 (0.77%)
At close: Nov 12, 2025
Edwards Lifesciences Market Cap
Edwards Lifesciences has a market cap or net worth of 263 billion as of November 13, 2025. Its market cap has increased by 10.36% in one year.
Market Cap
263.00B
Enterprise Value
246.33B
Revenue
31.36B
Ranking
n/a
PE Ratio
36.08
Stock Price
113.40
Market Cap Chart
Since March 27, 2000, Edwards Lifesciences's market cap has increased from 1.67B to 263.00B, an increase of 15,657.15%. That is a compound annual growth rate of 21.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2025 | 260.66B | -3.48% |
| Dec 31, 2024 | 270.05B | 20.34% |
| Dec 29, 2023 | 224.40B | -7.98% |
| Dec 30, 2022 | 243.86B | -45.89% |
| Dec 31, 2021 | 450.65B | 52.62% |
| Dec 31, 2020 | 295.28B | 50.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.14B |
| Raia Drogasil | 39.23B |
| Hypera | 16.31B |
| Fleury | 8.62B |
| Odontoprev | 6.72B |
| Empreendimentos Pague Menos | 2.94B |
| Diagnósticos da América | 2.56B |
| Blau Farmacêutica | 2.26B |